Skip to main content
. 2018 Jun 21;10(7):210. doi: 10.3390/cancers10070210

Figure 2.

Figure 2

Figure showing percentage of tumors harboring at least one targetable event in (a) EBV(+) NPC cohort (n = 111) and (b) HPV(+) HNSCC cohorts (n = 36; TCGA). The targetable genes include: BRCA1/2, SRC, LYN, YES1, ALK, VEGFA, EGFR, FGFR1/2/3/4, ERBB2/3/4, PDGFRA/B, JAK1/2/3, NTRK1/2/3, MET, PIK3CA, TSC1/2, MTOR, H/NRAS, BRAF, MAPK1/3, MAP2K1/2, NF1, NR2C2, PTPRD/T, PDCD1 and CD274 (PDCD1LG1). The percent cases with targetable genes mutation in each cohort are shown below each pie chart.